Quality of life (QoL) assessment of insulin detemir and NPH human insulin in Japanese subjects with diabetes on basal-bolus regimen

被引：0
|
作者：
Ishii, Hitoshi
Iwamoto, Yasuhiko
Kaku, Kohei
Kawamori, Ryuzo
Tajima, Naoko
Kobayashi, Masashi
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A710 / A710
页数：1
相关论文
共 50 条
  • [1] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [2] An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
    Palmer, Andrew J.
    Valentine, William J.
    Ray, Joshua A.
    Foos, Volker
    Lurati, Francesco
    Smith, Inger
    Lammert, Morten
    Roze, Stephane
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 895 - 901
  • [3] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    K. Hermansen
    P. Fontaine
    K. K. Kukolja
    V. Peterkova
    G. Leth
    M.-A. Gall
    Diabetologia, 2004, 47 : 622 - 629
  • [4] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    Hermansen, K
    Fontaine, P
    Kukolja, KK
    Peterkova, V
    Leth, G
    Gall, MA
    DIABETOLOGIA, 2004, 47 (04) : 622 - 629
  • [5] Comparison of the soluble basal insulin analog insulin detemir with NPH insulin - A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy
    Hermansen, K
    Madsbad, S
    Perrild, H
    Kristensen, A
    Axelsen, M
    DIABETES CARE, 2001, 24 (02) : 296 - 301
  • [6] The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Castellano E.
    Attanasio R.
    Giagulli V.A.
    Boriano A.
    Terzolo M.
    Papini E.
    Guastamacchia E.
    Monti S.
    Aglialoro A.
    Agrimi D.
    Ansaldi E.
    Babini A.C.
    Blatto A.
    Brancato D.
    Casile C.
    Cassibba S.
    Crescenti C.
    De Feo M.L.
    Del Prete A.
    Disoteo O.
    Ermetici F.
    Fiore V.
    Fusco A.
    Gioia D.
    Grassi A.
    Gullo D.
    Lo Pomo F.
    Miceli A.
    Nizzoli M.
    Pellegrino M.
    Pirali B.
    Santini C.
    Settembrini S.
    Tortato E.
    Triggiani V.
    Vacirca A.
    Borretta G.
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 393 - 399
  • [7] Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
    Vague, P
    Selam, JL
    Skeie, S
    De Leeuw, I
    Elte, JWF
    Haahr, H
    Kristensen, A
    Draeger, E
    DIABETES CARE, 2003, 26 (03) : 590 - 596
  • [8] Insulin detemir and insulin aspart:: A promising basal-bolus regimen for type 2 diabetes (vol 66, pg 193, 2004)
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hâncu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 72 (01) : 112 - 112
  • [9] Is changing from NPH insulin to insulin glargine as basal insulin in a basal bolus regimen effective in Japanese diabetic patients?
    Matsudaira, Toru
    Nishimura, Rimei
    Sano, Hirinari
    Miyashita, Yumi
    Morimoto, Aya
    Nishimura, Takashi
    Agata, Toshihiko
    Shimizu, Hidesuke
    Tajima, Naoko
    DIABETES, 2007, 56 : A531 - A531
  • [10] Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Elena Castellano
    R. Attanasio
    V. A. Giagulli
    A. Boriano
    M. Terzolo
    E. Papini
    E. Guastamacchia
    S. Monti
    A. Aglialoro
    D. Agrimi
    E. Ansaldi
    A. C. Babini
    A. Blatto
    D. Brancato
    C. Casile
    S. Cassibba
    C. Crescenti
    M. L. De Feo
    A. Del Prete
    O. Disoteo
    F. Ermetici
    V. Fiore
    A. Fusco
    D. Gioia
    A. Grassi
    D. Gullo
    F. Lo Pomo
    A. Miceli
    M. Nizzoli
    M. Pellegrino
    B. Pirali
    C. Santini
    S. Settembrini
    E. Tortato
    V. Triggiani
    A. Vacirca
    G. Borretta
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 401 - 402
12345